Optimization of extraction conditions for LC-ToF-MS analysis of mevalonate pathway metabolites in engineered E. coli strain via statistical experimental designs
Isoprenoids give rise to many functional products used today such as flavours, fragrances and even pharmaceutical compounds. Mevalonate pathway metabolites are the key intermediates that affect the production yield of isoprenoids. With increasing demand and benefit of isoprenoids, the present study...
Gespeichert in:
Veröffentlicht in: | Talanta (Oxford) 2023-03, Vol.254, p.124182-124182, Article 124182 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 124182 |
---|---|
container_issue | |
container_start_page | 124182 |
container_title | Talanta (Oxford) |
container_volume | 254 |
creator | Ng, Pnelope Khoo, Leng Wei Thong, Aaron Chew, Wee |
description | Isoprenoids give rise to many functional products used today such as flavours, fragrances and even pharmaceutical compounds. Mevalonate pathway metabolites are the key intermediates that affect the production yield of isoprenoids. With increasing demand and benefit of isoprenoids, the present study adopts Analytical Quality-by-Design (AQbD) approach to establish an efficacious extraction protocol prior to the determination of mevalonate pathway metabolites in an engineered Escherichia coli model. The statistical experimental design approach, described in this work, has successfully validated an optimised sample preparation method i.e., using acetonitrile: 50 mM ammonium formate (pH 9.5) (7:3) (ACN73) at -20 °C for 10 min without solvent evaporation to retain the targeted mevalonate metabolites in engineered E. coli strain. The study also demonstrates the use of liquid chromatography paired with a Time-of-Flight Mass Spectrometer (LC-ToF-MS) for the quantitative analysis of the mevalonate pathway metabolites in E. coli. The analytical method was validated in accordance with guidelines in Metabolomics Standards Initiative and ICH Q2 (R1) with analyte spike recoveries at 80% and above. In short, the present study overcomes the one-variable-at-a-time (OVAT) limitations in analytical development, minimises metabolite losses and gives better cost and time efficiencies by eliminating the solvent evaporation and swapping process. This work highlights the importance of analytical methods development in microbial metabolomics studies.
[Display omitted]
•Sampling and extraction of mevalonate (MVA) secondary pathway metabolites in E. coli was developed.•Reduced combinatorial and D-optimal DoE designs facilitated analytical method development.•UPLC-ToF-MS is validated to quantify MVA, MVAP, MVAPP, IPP, GPP, and FPP.•ACN:50 mM AF (pH 9.5), −20 °C, 10 min without solvent evaporation was proposed. |
doi_str_mv | 10.1016/j.talanta.2022.124182 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2755581917</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S003991402200978X</els_id><sourcerecordid>2755581917</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-5651fc2f8ebb115ab552da3dd07bc54c947fd6c767e140c2ad809744d39fe96e3</originalsourceid><addsrcrecordid>eNqFUctu1DAUtRCIDoVPAHnJJsGPOE5WCI1aQJqqi7Zry7FvikeJHWzPwPA1_VQ8zMCW1X343Ht87kHoLSU1JbT9sK2znrTPumaEsZqyhnbsGVrRTvKKC8mfoxUhvK962pAL9CqlLSGEccJfogveCiZ7ylbo6XbJbna_dHbB4zBi-JmjNn8qE7x1xyzhMUS8WVf34bq6ucPa6-mQXDriZ9jrKXidAS86f_uhD6WV9RAmlyFh5zH4R-cBIlh8VZelk8OpcJSXvdMlLdQpO6Onwr1AdDMUVRO2kNyjT6_Ri1FPCd6c4yV6uL66X3-pNrefv64_bSpTxORKtIKOho0dDAOlQg9CMKu5tUQORjSmb-RoWyNbCeUehmnbkV42jeX9CH0L_BK9P-1dYvi-g5TV7JKBqdwYwi4pJoUQHe2pLFBxgpoYUoowqqX8WseDokQdzVFbdTZHHc1RJ3PK3LszxW6Ywf6b-utGAXw8AaAI3TuIKhkH3oB1EUxWNrj_UPwGcGSm3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2755581917</pqid></control><display><type>article</type><title>Optimization of extraction conditions for LC-ToF-MS analysis of mevalonate pathway metabolites in engineered E. coli strain via statistical experimental designs</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Ng, Pnelope ; Khoo, Leng Wei ; Thong, Aaron ; Chew, Wee</creator><creatorcontrib>Ng, Pnelope ; Khoo, Leng Wei ; Thong, Aaron ; Chew, Wee</creatorcontrib><description>Isoprenoids give rise to many functional products used today such as flavours, fragrances and even pharmaceutical compounds. Mevalonate pathway metabolites are the key intermediates that affect the production yield of isoprenoids. With increasing demand and benefit of isoprenoids, the present study adopts Analytical Quality-by-Design (AQbD) approach to establish an efficacious extraction protocol prior to the determination of mevalonate pathway metabolites in an engineered Escherichia coli model. The statistical experimental design approach, described in this work, has successfully validated an optimised sample preparation method i.e., using acetonitrile: 50 mM ammonium formate (pH 9.5) (7:3) (ACN73) at -20 °C for 10 min without solvent evaporation to retain the targeted mevalonate metabolites in engineered E. coli strain. The study also demonstrates the use of liquid chromatography paired with a Time-of-Flight Mass Spectrometer (LC-ToF-MS) for the quantitative analysis of the mevalonate pathway metabolites in E. coli. The analytical method was validated in accordance with guidelines in Metabolomics Standards Initiative and ICH Q2 (R1) with analyte spike recoveries at 80% and above. In short, the present study overcomes the one-variable-at-a-time (OVAT) limitations in analytical development, minimises metabolite losses and gives better cost and time efficiencies by eliminating the solvent evaporation and swapping process. This work highlights the importance of analytical methods development in microbial metabolomics studies.
[Display omitted]
•Sampling and extraction of mevalonate (MVA) secondary pathway metabolites in E. coli was developed.•Reduced combinatorial and D-optimal DoE designs facilitated analytical method development.•UPLC-ToF-MS is validated to quantify MVA, MVAP, MVAPP, IPP, GPP, and FPP.•ACN:50 mM AF (pH 9.5), −20 °C, 10 min without solvent evaporation was proposed.</description><identifier>ISSN: 0039-9140</identifier><identifier>EISSN: 1873-3573</identifier><identifier>DOI: 10.1016/j.talanta.2022.124182</identifier><identifier>PMID: 36527912</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Chromatography, Liquid - methods ; Design of experiment (DoE) ; Engineered Escherichia coli ; Escherichia coli - metabolism ; Extraction ; Fast filtration sampling ; LC-ToF-MS ; Mevalonate pathway ; Mevalonic Acid - metabolism ; Research Design ; Solvents ; Terpenes</subject><ispartof>Talanta (Oxford), 2023-03, Vol.254, p.124182-124182, Article 124182</ispartof><rights>2022 Elsevier B.V.</rights><rights>Copyright © 2022 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-5651fc2f8ebb115ab552da3dd07bc54c947fd6c767e140c2ad809744d39fe96e3</citedby><cites>FETCH-LOGICAL-c365t-5651fc2f8ebb115ab552da3dd07bc54c947fd6c767e140c2ad809744d39fe96e3</cites><orcidid>0000-0002-9432-0560 ; 0000-0003-1244-1009</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.talanta.2022.124182$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36527912$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ng, Pnelope</creatorcontrib><creatorcontrib>Khoo, Leng Wei</creatorcontrib><creatorcontrib>Thong, Aaron</creatorcontrib><creatorcontrib>Chew, Wee</creatorcontrib><title>Optimization of extraction conditions for LC-ToF-MS analysis of mevalonate pathway metabolites in engineered E. coli strain via statistical experimental designs</title><title>Talanta (Oxford)</title><addtitle>Talanta</addtitle><description>Isoprenoids give rise to many functional products used today such as flavours, fragrances and even pharmaceutical compounds. Mevalonate pathway metabolites are the key intermediates that affect the production yield of isoprenoids. With increasing demand and benefit of isoprenoids, the present study adopts Analytical Quality-by-Design (AQbD) approach to establish an efficacious extraction protocol prior to the determination of mevalonate pathway metabolites in an engineered Escherichia coli model. The statistical experimental design approach, described in this work, has successfully validated an optimised sample preparation method i.e., using acetonitrile: 50 mM ammonium formate (pH 9.5) (7:3) (ACN73) at -20 °C for 10 min without solvent evaporation to retain the targeted mevalonate metabolites in engineered E. coli strain. The study also demonstrates the use of liquid chromatography paired with a Time-of-Flight Mass Spectrometer (LC-ToF-MS) for the quantitative analysis of the mevalonate pathway metabolites in E. coli. The analytical method was validated in accordance with guidelines in Metabolomics Standards Initiative and ICH Q2 (R1) with analyte spike recoveries at 80% and above. In short, the present study overcomes the one-variable-at-a-time (OVAT) limitations in analytical development, minimises metabolite losses and gives better cost and time efficiencies by eliminating the solvent evaporation and swapping process. This work highlights the importance of analytical methods development in microbial metabolomics studies.
[Display omitted]
•Sampling and extraction of mevalonate (MVA) secondary pathway metabolites in E. coli was developed.•Reduced combinatorial and D-optimal DoE designs facilitated analytical method development.•UPLC-ToF-MS is validated to quantify MVA, MVAP, MVAPP, IPP, GPP, and FPP.•ACN:50 mM AF (pH 9.5), −20 °C, 10 min without solvent evaporation was proposed.</description><subject>Chromatography, Liquid - methods</subject><subject>Design of experiment (DoE)</subject><subject>Engineered Escherichia coli</subject><subject>Escherichia coli - metabolism</subject><subject>Extraction</subject><subject>Fast filtration sampling</subject><subject>LC-ToF-MS</subject><subject>Mevalonate pathway</subject><subject>Mevalonic Acid - metabolism</subject><subject>Research Design</subject><subject>Solvents</subject><subject>Terpenes</subject><issn>0039-9140</issn><issn>1873-3573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUctu1DAUtRCIDoVPAHnJJsGPOE5WCI1aQJqqi7Zry7FvikeJHWzPwPA1_VQ8zMCW1X343Ht87kHoLSU1JbT9sK2znrTPumaEsZqyhnbsGVrRTvKKC8mfoxUhvK962pAL9CqlLSGEccJfogveCiZ7ylbo6XbJbna_dHbB4zBi-JmjNn8qE7x1xyzhMUS8WVf34bq6ucPa6-mQXDriZ9jrKXidAS86f_uhD6WV9RAmlyFh5zH4R-cBIlh8VZelk8OpcJSXvdMlLdQpO6Onwr1AdDMUVRO2kNyjT6_Ri1FPCd6c4yV6uL66X3-pNrefv64_bSpTxORKtIKOho0dDAOlQg9CMKu5tUQORjSmb-RoWyNbCeUehmnbkV42jeX9CH0L_BK9P-1dYvi-g5TV7JKBqdwYwi4pJoUQHe2pLFBxgpoYUoowqqX8WseDokQdzVFbdTZHHc1RJ3PK3LszxW6Ywf6b-utGAXw8AaAI3TuIKhkH3oB1EUxWNrj_UPwGcGSm3g</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Ng, Pnelope</creator><creator>Khoo, Leng Wei</creator><creator>Thong, Aaron</creator><creator>Chew, Wee</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9432-0560</orcidid><orcidid>https://orcid.org/0000-0003-1244-1009</orcidid></search><sort><creationdate>20230301</creationdate><title>Optimization of extraction conditions for LC-ToF-MS analysis of mevalonate pathway metabolites in engineered E. coli strain via statistical experimental designs</title><author>Ng, Pnelope ; Khoo, Leng Wei ; Thong, Aaron ; Chew, Wee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-5651fc2f8ebb115ab552da3dd07bc54c947fd6c767e140c2ad809744d39fe96e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chromatography, Liquid - methods</topic><topic>Design of experiment (DoE)</topic><topic>Engineered Escherichia coli</topic><topic>Escherichia coli - metabolism</topic><topic>Extraction</topic><topic>Fast filtration sampling</topic><topic>LC-ToF-MS</topic><topic>Mevalonate pathway</topic><topic>Mevalonic Acid - metabolism</topic><topic>Research Design</topic><topic>Solvents</topic><topic>Terpenes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ng, Pnelope</creatorcontrib><creatorcontrib>Khoo, Leng Wei</creatorcontrib><creatorcontrib>Thong, Aaron</creatorcontrib><creatorcontrib>Chew, Wee</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Talanta (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ng, Pnelope</au><au>Khoo, Leng Wei</au><au>Thong, Aaron</au><au>Chew, Wee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimization of extraction conditions for LC-ToF-MS analysis of mevalonate pathway metabolites in engineered E. coli strain via statistical experimental designs</atitle><jtitle>Talanta (Oxford)</jtitle><addtitle>Talanta</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>254</volume><spage>124182</spage><epage>124182</epage><pages>124182-124182</pages><artnum>124182</artnum><issn>0039-9140</issn><eissn>1873-3573</eissn><abstract>Isoprenoids give rise to many functional products used today such as flavours, fragrances and even pharmaceutical compounds. Mevalonate pathway metabolites are the key intermediates that affect the production yield of isoprenoids. With increasing demand and benefit of isoprenoids, the present study adopts Analytical Quality-by-Design (AQbD) approach to establish an efficacious extraction protocol prior to the determination of mevalonate pathway metabolites in an engineered Escherichia coli model. The statistical experimental design approach, described in this work, has successfully validated an optimised sample preparation method i.e., using acetonitrile: 50 mM ammonium formate (pH 9.5) (7:3) (ACN73) at -20 °C for 10 min without solvent evaporation to retain the targeted mevalonate metabolites in engineered E. coli strain. The study also demonstrates the use of liquid chromatography paired with a Time-of-Flight Mass Spectrometer (LC-ToF-MS) for the quantitative analysis of the mevalonate pathway metabolites in E. coli. The analytical method was validated in accordance with guidelines in Metabolomics Standards Initiative and ICH Q2 (R1) with analyte spike recoveries at 80% and above. In short, the present study overcomes the one-variable-at-a-time (OVAT) limitations in analytical development, minimises metabolite losses and gives better cost and time efficiencies by eliminating the solvent evaporation and swapping process. This work highlights the importance of analytical methods development in microbial metabolomics studies.
[Display omitted]
•Sampling and extraction of mevalonate (MVA) secondary pathway metabolites in E. coli was developed.•Reduced combinatorial and D-optimal DoE designs facilitated analytical method development.•UPLC-ToF-MS is validated to quantify MVA, MVAP, MVAPP, IPP, GPP, and FPP.•ACN:50 mM AF (pH 9.5), −20 °C, 10 min without solvent evaporation was proposed.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36527912</pmid><doi>10.1016/j.talanta.2022.124182</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-9432-0560</orcidid><orcidid>https://orcid.org/0000-0003-1244-1009</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0039-9140 |
ispartof | Talanta (Oxford), 2023-03, Vol.254, p.124182-124182, Article 124182 |
issn | 0039-9140 1873-3573 |
language | eng |
recordid | cdi_proquest_miscellaneous_2755581917 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Chromatography, Liquid - methods Design of experiment (DoE) Engineered Escherichia coli Escherichia coli - metabolism Extraction Fast filtration sampling LC-ToF-MS Mevalonate pathway Mevalonic Acid - metabolism Research Design Solvents Terpenes |
title | Optimization of extraction conditions for LC-ToF-MS analysis of mevalonate pathway metabolites in engineered E. coli strain via statistical experimental designs |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T18%3A56%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimization%20of%20extraction%20conditions%20for%20LC-ToF-MS%20analysis%20of%20mevalonate%20pathway%20metabolites%20in%20engineered%20E.%20coli%20strain%20via%20statistical%20experimental%20designs&rft.jtitle=Talanta%20(Oxford)&rft.au=Ng,%20Pnelope&rft.date=2023-03-01&rft.volume=254&rft.spage=124182&rft.epage=124182&rft.pages=124182-124182&rft.artnum=124182&rft.issn=0039-9140&rft.eissn=1873-3573&rft_id=info:doi/10.1016/j.talanta.2022.124182&rft_dat=%3Cproquest_cross%3E2755581917%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2755581917&rft_id=info:pmid/36527912&rft_els_id=S003991402200978X&rfr_iscdi=true |